DK0465581T3 - Erythromycinderivater - Google Patents

Erythromycinderivater

Info

Publication number
DK0465581T3
DK0465581T3 DK90906030.3T DK90906030T DK0465581T3 DK 0465581 T3 DK0465581 T3 DK 0465581T3 DK 90906030 T DK90906030 T DK 90906030T DK 0465581 T3 DK0465581 T3 DK 0465581T3
Authority
DK
Denmark
Prior art keywords
pct
erythromycin derivatives
sec
disclosed
erythromycin
Prior art date
Application number
DK90906030.3T
Other languages
Danish (da)
English (en)
Inventor
Leslie A Freiberg
Larry L Klein
Clinton M Yeung
Carla M Edwards
David J Bacino
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0465581T3 publication Critical patent/DK0465581T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90906030.3T 1989-03-28 1990-03-28 Erythromycinderivater DK0465581T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32947389A 1989-03-28 1989-03-28

Publications (1)

Publication Number Publication Date
DK0465581T3 true DK0465581T3 (da) 1996-02-12

Family

ID=23285572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90906030.3T DK0465581T3 (da) 1989-03-28 1990-03-28 Erythromycinderivater

Country Status (14)

Country Link
US (1) US5288709A (de)
EP (1) EP0465581B1 (de)
JP (1) JPH04504259A (de)
KR (1) KR920701229A (de)
AT (1) ATE128714T1 (de)
AU (1) AU623764B2 (de)
CA (1) CA2049359A1 (de)
DE (1) DE69022845T2 (de)
DK (1) DK0465581T3 (de)
ES (1) ES2080140T3 (de)
GR (1) GR1000519B (de)
IL (1) IL93936A (de)
NZ (1) NZ233117A (de)
WO (1) WO1990011288A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0549040A1 (de) * 1991-12-20 1993-06-30 Merck & Co. Inc. Verfahren zur Herstellung von 4"-Derivaten von 9-Deoxo-8a-Aza-8a-Alkyl-8a-Homoerythromycin A
FR2713226B1 (fr) * 1993-12-03 1996-01-05 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
CN1166172A (zh) * 1995-08-03 1997-11-26 达德化学系统公司 奎尼定缀合物及其在免疫测定中的应用
EP0895999A1 (de) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4"-substituierte Macrolidantibiotica
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
WO2003090760A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories Oxolide antibacterials
SI1532131T1 (sl) * 2002-08-29 2009-04-30 Pfizer Motilidne spojine
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
ES2278319T3 (es) * 2003-05-13 2007-08-01 Glaxo Group Limited Nuevos compuestos con 14 y 15 miembros en el anillo.
GB0310986D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
CN107365338B (zh) * 2016-08-12 2021-03-19 西安世纪盛康药业有限公司 一类红霉素a-6,9-9,12-螺缩酮衍生物及其制备方法和应用
CN114504585A (zh) * 2020-11-16 2022-05-17 中国人民解放军海军军医大学 一种大环内酯类衍生物在制备减重降糖药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1451798A (en) * 1973-08-02 1976-10-06 Ici Ltd Prostanoic acid derivatives
US3963696A (en) * 1975-02-21 1976-06-15 Abbott Laboratories 6,6A-AND 6,7-Anhydroerythromycin B and derivatives thereof
EP0184921A3 (de) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycinderivate
US5008249A (en) * 1985-08-31 1991-04-16 Kitasato Kenkyusho Therapeutic method of stimulating digestive tract contractile motion in mammals
SE519436C2 (sv) * 2001-04-09 2003-02-25 Anoto Ab Penna med på pennan löstagbart anordnade medel för byte av i pennan anordnat bläckstift, samt förfarande för stiftbyte

Also Published As

Publication number Publication date
KR920701229A (ko) 1992-08-11
EP0465581A1 (de) 1992-01-15
AU5402890A (en) 1990-10-22
DE69022845D1 (en) 1995-11-09
WO1990011288A1 (en) 1990-10-04
EP0465581A4 (en) 1992-05-13
GR900100232A (en) 1990-07-31
JPH04504259A (ja) 1992-07-30
DE69022845T2 (de) 1996-06-13
IL93936A (en) 1994-06-24
CA2049359A1 (en) 1990-09-29
ATE128714T1 (de) 1995-10-15
ES2080140T3 (es) 1996-02-01
IL93936A0 (en) 1990-12-23
NZ233117A (en) 1991-05-28
GR1000519B (el) 1992-08-25
US5288709A (en) 1994-02-22
EP0465581B1 (de) 1995-10-04
AU623764B2 (en) 1992-05-21

Similar Documents

Publication Publication Date Title
NO931635L (no) Fremgangsmaate for fremstilling av kinazolin-derivater
DK0611522T3 (da) Synergistiske mikrobicide sammensætninger
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
ATE128714T1 (de) Erythromycinderivate.
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
IT8720200A0 (it) Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine.
ES2013727B3 (es) Procedimiento para la fabricacion de articulos de cerdas y articulos de cerdas fabricadas por dicho procedimiento.
DE68918944D1 (de) Künstliche rezeptor-analoge.
NO900643L (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
EP0237829A3 (en) Tetrahydro-3,4-furandiamine-n-n'-platinum complexes
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
ATE311399T1 (de) 2'-deoxy-4'-thioribonucleoside als antivirale und antikrebsmittel
ATE60574T1 (de) Hydroxylierte 1,2-diamincyclohexan platinkomplexe.
DE4092406A1 (de)
ATE132500T1 (de) 24r-scymnol, herstellung und verwendung
FI905350A0 (fi) Komposition innehaollande maerkta streptokock-antikroppar,testfoerpackning och analysfoerfarande, i vilket den anvaends.
NO911798L (no) 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling.
DE69006508D1 (de) Azeotropähnliche zusammensetzungen von 1,3-dichlor-1,1,2,2,3-pentafluorpropan und 2-methyl-2-propanol.
PT86665A (pt) Process for the preparation of 14,15-substituted lanosterols and of hypocholesterolemic compositions containing the same
ATE97909T1 (de) Antibiotikum n-acetylbenanomicin b, dessen herstellung und verwendung.
FI853585A7 (fi) Menetelmä aromaattisten 1,4-oksatsepinonien ja -tionien valmistamiseksi.
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.